Roche breaking ground on Dx expansion; Tornier CEO steps aside;

 @FierceMedDev: Chinese device maker Dehaier Medical saw Q3 revenue dip. The reason: an expansion strategy has yet to fully take hold. More | Follow @FierceMedDev

 @MarkHFierce: PerkinElmer snatched up an infectious disease Dx company based in China. More | Follow @MarkHFierce

 @DamianFierce: Hologic took a dive in the last quarter but predicts its $3.8B Gen-Probe buy will brighten the future. Story | Follow @DamianFierce

> Response Genetics ($RGDX) narrowed its quarterly losses to $1.4 million in Q3, growing revenue by 6% to $5.4 million. More

> Tornier Medical ($TRNX) CEO Douglas Kohrs is retiring from the company, and COO David Mowry will serve in the interim while Tornier searches for a permanent chief. Report

> In Italy, authorities have arrested 9 cardiologists for participating in illegal and unauthorized clinical trials. The investigation is said to implicate 67 others and 12 medical equipment companies. Story

> Roche Diagnostics ($RHHBY) is set to break ground Wednesday on Phase I of its $300 million expansion in Indianapolis. News

> Stryker ($SYK) has signed on with Wineman Technology, tasking the company with developing 5 life-cycle and durability test systems for its devices. Release

> Is St. Jude Medical ($STJ) on pace to rebound or doomed to tank? Two analysts have widely divergent takes. Item

Biotech News

 @FierceBiotech: Trending on FierceBiotech.com: 10 Top Women in Biotech 2012. Special Report | Follow @FierceBiotech

 @JohnCFierce: Alnylam to pay $75M to settle legal squabble over Tekmira's RNAi delivery tech. Story | Follow @JohnCFierce

 @RyanMFierce: $GILD is looking smart today for buying 7977. Market cap appears to have jumped $6.8B yesterday on news of its 100% SVR with hep C slayer. | Follow @RyanMFierce

> Fast-growing Gilead Sciences blueprints expansion, new R&D hires. News

> Pearl lands $65M round to fuel PhIII COPD showdown with Novartis, GSK. Story

Pharma News

@FiercePharma: Israeli legal scholars move to sue Teva for shrouding details on executive pay. More | Follow @FiercePharma

> GSK ($GSK) rep wears dunce cap for off-label breach in U.K. Article

> Boycott Roche ($RHHBY) to open Tamiflu data, critic says. News

Biotech Research News

> Harvard's microchip, lined with living cells, mimics disease in preclinical drug test. Report

> Stem cells produce the next potential Alzheimer's treatment. Item

> Kancera credits new drug with slowing pancreatic cancer tumor growth. Article

> Anti-inflammatory drugs that minimize infection risk appear possible. News

> Scientists crack genetic code for rare childhood leukemia variation. Story

Pharma Manufacturing News

> Lundbeck manufacturing starts small in China. Report

> Orchid closing up shop in China. More

> EFCG demands EU inspections of foreign API makers. Article

> FDA confirms Novartis plant, renewing CEO's confidence. Story

> Pilot shows national track and trace 'not insurmountable'. Editor's Corner

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.